Skip to main content
. 2013 May 22;1(4):563–566. doi: 10.3892/br.2013.113

Table III.

SNP sites exhibiting frequency differences between ccRCC patients and controls.

Nucleotide ccRCC (n=59) Control (n=68) χ2 P-value
262A/G 43/16 (27.1%) 68/0 (0%) 21.099 0.000
16293A/G 48/11 (18.6%) 66/2 (2.9%) 8.478 0.004
16298T/C 55/4 (6.8%) 54/14 (20.6%) 4.952 0.026
16319G/A 55/4 (6.8%) 55/13 (19.1%) 4.418 0.042

SNP, single-nucleotide polymorphism; ccRCC, clear cell renal cell carcinoma.